Dr. Paul Lasko, Scientific Director of the CIHR’s Institute of Genetics (CIHR-IG), Dr. Stephen Robbins Scientific Director of CIHR’s Institute of Cancer Research (CIHR-ICR) and Dr. Jean L. Rouleau, Scientific Director of CIHR’s Institute of Circulatory and Respiratory Health (CIHR-ICRH) are pleased to announce the 13th Annual New Principal Investigators Meeting (November 21-23, 2014, Mont Gabriel, Québec).
The 13th Annual New Principal Investigators Meeting will be a mentorship and networking event designed to strengthen the professional development of junior faculty working in related or overlapping fields. Virtually without exception, the more than 1,300 New PIs who have attended one of the previous New PI meetings have declared it to be a valuable experience.
The format of this year's meeting will include presentations covering a range of health research of common interest to the three sponsoring CIHR Institutes, including basic, clinical, applied and health services and policy research. Investigators will describe their recent research and indicate what was critical to their developing a successful research career. Established scientists will also lead workshops on grant writing, the mechanics of peer review, and the administrative and human resource challenges of running a laboratory or research team.
IG supports research on the human and model genomes and on all aspects of genetics, basic biochemistry and cell biology related to health and disease, including the translation of knowledge into health policy and practice, and the societal implications of genetic discoveries. ICR supports research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation, towards providing effective customized cancer care and decreasing mortality from cancer. ICRH supports research to into the causes, mechanisms, prevention, screening, diagnosis, treatment, support systems and palliation for a wide range of conditions associated with the heart, lung, brain (stroke), blood vessels, blood, critical and intensive care, and sleep.
Participants need not hold a CIHR grant, but should identify at least one of the three sponsoring Institutes as their primary or secondary CIHR Institute affiliation. Candidates are nominated by Senior Investigators, and have a significant portion of their costs covered by CIHR. Applications are accepted primarily on a first-come first-served basis.